Home › Desmoplastic Small Round Cell Tumor › New York
Desmoplastic Small Round Cell Tumor clinical trials in New York
3 studies for Desmoplastic Small Round Cell Tumor are looking for participants at sites in New York.
Cities in New York
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- New York Medical College, Valhalla
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560Lurbinectedin in FET-Fused Tumors
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 10 and older · All sexes · Updated Sep 2, 2026 · NCT05918640Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RecruitingObservational study
All ages · All sexes · Updated Jan 12, 2026 · NCT04690374From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.